Market Highlight Middle East and Africa Smoking Cessation and Nicotine De-Addiction Market

Smoking cessation and nicotine de-addiction are drugs and therapies used in the treatment of withdrawal symptoms associated with the cessation of nicotine.

According to the World Health Organization tobacco kills around 6 million people each year and of these almost 5 million deaths are the result of direct tobacco use and approximately 600,000 are the result of passive ... Read more

Middle East and Africa Smoking Cessation and Nicotine De-Addiction Market Information, by Treatment (pharmacological, therapies and others), by Product Type (drugs, inhalers, patches, sprays & gums and others), Distribution Channels (pharmacies, online, de-addiction centers) - Forecast to 2022. Smoking cessation and nicotine de-addiction are drugs and therapies used in the treatment of withdrawal symptoms associated with the cessation of nicotine. As indicated by the World Health ... Read more

Smoking Cessation and Nicotine De-Addiction Market Huge Interested Key Players Involved: Novartis International AG, Cipla Inc., and GlaxoSmithKline plc. Nicotek LLC., and Lorillard, IPfizer Inc., VMR Products LLC, Johnson & Johnson, nc. and others.

Smoking Cessation and Nicotine De-Addiction Market for Middle East and Africa was estimated to be around $ 1040 million in 2016. Taking all factors into consideration, we expect the Middle East and ... Read more